CATCH-UP vaccines: protocol for a randomized controlled trial using the multiphase optimization strategy (MOST) framework to evaluate education interventions to increase COVID-19 vaccine uptake in Oklahoma
Oklahoma's cumulative COVID-19 incidence is higher in rural than urban counties and higher than the overall US incidence. Furthermore, fewer Oklahomans have received at least one COVID-19 vaccine compared to the US average. Our goal is to conduct a randomized controlled trial using the multipha...
Saved in:
Published in | BMC public health Vol. 23; no. 1; pp. 1146 - 11 |
---|---|
Main Authors | , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
BioMed Central Ltd
14.06.2023
BioMed Central BMC |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Oklahoma's cumulative COVID-19 incidence is higher in rural than urban counties and higher than the overall US incidence. Furthermore, fewer Oklahomans have received at least one COVID-19 vaccine compared to the US average. Our goal is to conduct a randomized controlled trial using the multiphase optimization strategy (MOST) to test multiple educational interventions to improve uptake of COVID-19 vaccination among underserved populations in Oklahoma.
Our study uses the preparation and optimization phases of the MOST framework. We conduct focus groups among community partners and community members previously involved in hosting COVID-19 testing events to inform intervention design (preparation). In a randomized clinical trial, we test three interventions to improve vaccination uptake: (1) process improvement (text messages); (2) barrier elicitation and reduction (electronic survey with tailored questions/prompts); and (2) teachable moment messaging (motivational interviewing) in a three-factor fully crossed factorial design (optimization).
Because of Oklahoma's higher COVID-19 impact and lower vaccine uptake, identifying community-driven interventions is critical to address vaccine hesitancy. The MOST framework provides an innovative and timely opportunity to efficiently evaluate multiple educational interventions in a single study.
ClinicalTrials.gov: NCT05236270, First Posted: February 11, 2022, Last Update Posted: August 31, 2022. |
---|---|
AbstractList | Abstract Background Oklahoma’s cumulative COVID-19 incidence is higher in rural than urban counties and higher than the overall US incidence. Furthermore, fewer Oklahomans have received at least one COVID-19 vaccine compared to the US average. Our goal is to conduct a randomized controlled trial using the multiphase optimization strategy (MOST) to test multiple educational interventions to improve uptake of COVID-19 vaccination among underserved populations in Oklahoma. Methods Our study uses the preparation and optimization phases of the MOST framework. We conduct focus groups among community partners and community members previously involved in hosting COVID-19 testing events to inform intervention design (preparation). In a randomized clinical trial, we test three interventions to improve vaccination uptake: (1) process improvement (text messages); (2) barrier elicitation and reduction (electronic survey with tailored questions/prompts); and (2) teachable moment messaging (motivational interviewing) in a three-factor fully crossed factorial design (optimization). Discussion Because of Oklahoma’s higher COVID-19 impact and lower vaccine uptake, identifying community-driven interventions is critical to address vaccine hesitancy. The MOST framework provides an innovative and timely opportunity to efficiently evaluate multiple educational interventions in a single study. Trial Registration ClinicalTrials.gov: NCT05236270, First Posted: February 11, 2022, Last Update Posted: August 31, 2022. BackgroundOklahoma’s cumulative COVID-19 incidence is higher in rural than urban counties and higher than the overall US incidence. Furthermore, fewer Oklahomans have received at least one COVID-19 vaccine compared to the US average. Our goal is to conduct a randomized controlled trial using the multiphase optimization strategy (MOST) to test multiple educational interventions to improve uptake of COVID-19 vaccination among underserved populations in Oklahoma.MethodsOur study uses the preparation and optimization phases of the MOST framework. We conduct focus groups among community partners and community members previously involved in hosting COVID-19 testing events to inform intervention design (preparation). In a randomized clinical trial, we test three interventions to improve vaccination uptake: (1) process improvement (text messages); (2) barrier elicitation and reduction (electronic survey with tailored questions/prompts); and (2) teachable moment messaging (motivational interviewing) in a three-factor fully crossed factorial design (optimization).DiscussionBecause of Oklahoma’s higher COVID-19 impact and lower vaccine uptake, identifying community-driven interventions is critical to address vaccine hesitancy. The MOST framework provides an innovative and timely opportunity to efficiently evaluate multiple educational interventions in a single study.Trial RegistrationClinicalTrials.gov: NCT05236270, First Posted: February 11, 2022, Last Update Posted: August 31, 2022. Background Oklahoma's cumulative COVID-19 incidence is higher in rural than urban counties and higher than the overall US incidence. Furthermore, fewer Oklahomans have received at least one COVID-19 vaccine compared to the US average. Our goal is to conduct a randomized controlled trial using the multiphase optimization strategy (MOST) to test multiple educational interventions to improve uptake of COVID-19 vaccination among underserved populations in Oklahoma. Methods Our study uses the preparation and optimization phases of the MOST framework. We conduct focus groups among community partners and community members previously involved in hosting COVID-19 testing events to inform intervention design (preparation). In a randomized clinical trial, we test three interventions to improve vaccination uptake: (1) process improvement (text messages); (2) barrier elicitation and reduction (electronic survey with tailored questions/prompts); and (2) teachable moment messaging (motivational interviewing) in a three-factor fully crossed factorial design (optimization). Discussion Because of Oklahoma's higher COVID-19 impact and lower vaccine uptake, identifying community-driven interventions is critical to address vaccine hesitancy. The MOST framework provides an innovative and timely opportunity to efficiently evaluate multiple educational interventions in a single study. Trial Registration ClinicalTrials.gov: NCT05236270, First Posted: February 11, 2022, Last Update Posted: August 31, 2022. Keywords: Multiphase optimization strategy, COVID-19, Vaccine hesitancy, Underserved communities, Rural health disparities, Community-engaged intervention Oklahoma's cumulative COVID-19 incidence is higher in rural than urban counties and higher than the overall US incidence. Furthermore, fewer Oklahomans have received at least one COVID-19 vaccine compared to the US average. Our goal is to conduct a randomized controlled trial using the multiphase optimization strategy (MOST) to test multiple educational interventions to improve uptake of COVID-19 vaccination among underserved populations in Oklahoma.BACKGROUNDOklahoma's cumulative COVID-19 incidence is higher in rural than urban counties and higher than the overall US incidence. Furthermore, fewer Oklahomans have received at least one COVID-19 vaccine compared to the US average. Our goal is to conduct a randomized controlled trial using the multiphase optimization strategy (MOST) to test multiple educational interventions to improve uptake of COVID-19 vaccination among underserved populations in Oklahoma.Our study uses the preparation and optimization phases of the MOST framework. We conduct focus groups among community partners and community members previously involved in hosting COVID-19 testing events to inform intervention design (preparation). In a randomized clinical trial, we test three interventions to improve vaccination uptake: (1) process improvement (text messages); (2) barrier elicitation and reduction (electronic survey with tailored questions/prompts); and (2) teachable moment messaging (motivational interviewing) in a three-factor fully crossed factorial design (optimization).METHODSOur study uses the preparation and optimization phases of the MOST framework. We conduct focus groups among community partners and community members previously involved in hosting COVID-19 testing events to inform intervention design (preparation). In a randomized clinical trial, we test three interventions to improve vaccination uptake: (1) process improvement (text messages); (2) barrier elicitation and reduction (electronic survey with tailored questions/prompts); and (2) teachable moment messaging (motivational interviewing) in a three-factor fully crossed factorial design (optimization).Because of Oklahoma's higher COVID-19 impact and lower vaccine uptake, identifying community-driven interventions is critical to address vaccine hesitancy. The MOST framework provides an innovative and timely opportunity to efficiently evaluate multiple educational interventions in a single study.DISCUSSIONBecause of Oklahoma's higher COVID-19 impact and lower vaccine uptake, identifying community-driven interventions is critical to address vaccine hesitancy. The MOST framework provides an innovative and timely opportunity to efficiently evaluate multiple educational interventions in a single study.ClinicalTrials.gov: NCT05236270, First Posted: February 11, 2022, Last Update Posted: August 31, 2022.TRIAL REGISTRATIONClinicalTrials.gov: NCT05236270, First Posted: February 11, 2022, Last Update Posted: August 31, 2022. Oklahoma's cumulative COVID-19 incidence is higher in rural than urban counties and higher than the overall US incidence. Furthermore, fewer Oklahomans have received at least one COVID-19 vaccine compared to the US average. Our goal is to conduct a randomized controlled trial using the multiphase optimization strategy (MOST) to test multiple educational interventions to improve uptake of COVID-19 vaccination among underserved populations in Oklahoma. Our study uses the preparation and optimization phases of the MOST framework. We conduct focus groups among community partners and community members previously involved in hosting COVID-19 testing events to inform intervention design (preparation). In a randomized clinical trial, we test three interventions to improve vaccination uptake: (1) process improvement (text messages); (2) barrier elicitation and reduction (electronic survey with tailored questions/prompts); and (2) teachable moment messaging (motivational interviewing) in a three-factor fully crossed factorial design (optimization). Because of Oklahoma's higher COVID-19 impact and lower vaccine uptake, identifying community-driven interventions is critical to address vaccine hesitancy. The MOST framework provides an innovative and timely opportunity to efficiently evaluate multiple educational interventions in a single study. ClinicalTrials.gov: NCT05236270, First Posted: February 11, 2022, Last Update Posted: August 31, 2022. Oklahoma's cumulative COVID-19 incidence is higher in rural than urban counties and higher than the overall US incidence. Furthermore, fewer Oklahomans have received at least one COVID-19 vaccine compared to the US average. Our goal is to conduct a randomized controlled trial using the multiphase optimization strategy (MOST) to test multiple educational interventions to improve uptake of COVID-19 vaccination among underserved populations in Oklahoma. Our study uses the preparation and optimization phases of the MOST framework. We conduct focus groups among community partners and community members previously involved in hosting COVID-19 testing events to inform intervention design (preparation). In a randomized clinical trial, we test three interventions to improve vaccination uptake: (1) process improvement (text messages); (2) barrier elicitation and reduction (electronic survey with tailored questions/prompts); and (2) teachable moment messaging (motivational interviewing) in a three-factor fully crossed factorial design (optimization). Because of Oklahoma's higher COVID-19 impact and lower vaccine uptake, identifying community-driven interventions is critical to address vaccine hesitancy. The MOST framework provides an innovative and timely opportunity to efficiently evaluate multiple educational interventions in a single study. |
ArticleNumber | 1146 |
Audience | Academic |
Author | Janitz, Amanda E. James, Judith A. Neil, Jordan M. Spicer, Paul G. Williams, Mary L. Doescher, Mark P. Bray, Laura A. Ross, Laura Lopez, April K. Chen, Sixia Jervis, Lori L. Campbell, Janis E. Uribe-Frias, Conce A. VanWagoner, Timothy M. |
Author_xml | – sequence: 1 givenname: Amanda E. surname: Janitz fullname: Janitz, Amanda E. – sequence: 2 givenname: Jordan M. surname: Neil fullname: Neil, Jordan M. – sequence: 3 givenname: Laura A. surname: Bray fullname: Bray, Laura A. – sequence: 4 givenname: Lori L. surname: Jervis fullname: Jervis, Lori L. – sequence: 5 givenname: Laura surname: Ross fullname: Ross, Laura – sequence: 6 givenname: Janis E. surname: Campbell fullname: Campbell, Janis E. – sequence: 7 givenname: Mark P. surname: Doescher fullname: Doescher, Mark P. – sequence: 8 givenname: Paul G. surname: Spicer fullname: Spicer, Paul G. – sequence: 9 givenname: Mary L. surname: Williams fullname: Williams, Mary L. – sequence: 10 givenname: April K. surname: Lopez fullname: Lopez, April K. – sequence: 11 givenname: Conce A. surname: Uribe-Frias fullname: Uribe-Frias, Conce A. – sequence: 12 givenname: Sixia surname: Chen fullname: Chen, Sixia – sequence: 13 givenname: Judith A. surname: James fullname: James, Judith A. – sequence: 14 givenname: Timothy M. surname: VanWagoner fullname: VanWagoner, Timothy M. |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/37316843$$D View this record in MEDLINE/PubMed |
BookMark | eNp9ks1u3CAUha0qVfPTvkAXFVI36cKpwcbgbqLR9C9SqqnUpFuE8WWGxIYp4InSd-w7FWeSNomqigVw-e6Bg85-tmOdhSx7iYsjjHn9NmDCeZMXpMxxXTCWXz3J9nDFcE4qynfurXez_RAuigIzTsmzbLdkJa55Ve5lv-azs_nn_Pwr2kiljIXwDq29i065HmnnkURe2s4N5id0SDkbvev7tIzeyB6NwdgliitAw9hHs17JAMito0m8jMZZFKKXEZbX6PDL4tvZG6S9HODK-UsUHYKN7Md0jKAb1ZY3NoLfgJ02YWKMVR4m2fni-8n7HDd3L0XjOspLSABaXPZy5Qb5PHuqZR_gxe18kJ1__DD5O118OpnPTnNF6yrmlcaKlRSzRjdVQ3QrSwa0YTVuK051m6ptW0NbV6XuKOka4LXsKq7ajnSqVOVBdrLV7Zy8EGtvBumvhZNG3BScXwrpo1E9CF0qraiEouNVVReSA5Wq0S0hDWcYk6R1vNVaj-0AnUrWvewfiD48sWYllm4jcEFqSilPCoe3Ct79GCFEMZigoO-lBTcGQTipCWa0mS57_Qi9cKO36a8mihUl54z_pZYyOTBWu3SxmkTFjNVVgasmJeggO_oHlUYHg0lJAW1S_UHDq_tO_1i8S2MC-BZQ3oXgQQtl4k0skrLpk2MxBV9sgy9S8MVN8MVVaiWPWu_U_9P0G2a5CUM |
CitedBy_id | crossref_primary_10_1371_journal_pone_0300872 crossref_primary_10_3389_fpubh_2024_1291332 |
Cites_doi | 10.1023/B:PREV.0000037641.26017.00 10.1016/j.vaccine.2022.12.050 10.1007/s40615-022-01471-8 10.1080/13548506.2020.1750663 10.1111/jrh.12481 10.1111/jrh.12555 10.1186/s12889-022-12900-y 10.1186/s13012-014-0169-x 10.1370/afm.1624 10.1177/2333721420936168 10.1016/j.japh.2022.01.013 10.1371/journal.pone.0248542 10.1186/s12889-022-13576-0 10.1016/j.vaccine.2022.07.045 10.1016/j.ypmed.2022.107415 10.3122/jabfm.2008.04.080006 10.3122/jabfm.2017.05.170035 10.1057/s41599-022-01439-3 10.1007/s10461-015-1145-4 10.2196/39109 10.15585/mmwr.mm7006e3 |
ContentType | Journal Article |
Copyright | 2023. The Author(s). COPYRIGHT 2023 BioMed Central Ltd. 2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. The Author(s) 2023 |
Copyright_xml | – notice: 2023. The Author(s). – notice: COPYRIGHT 2023 BioMed Central Ltd. – notice: 2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: The Author(s) 2023 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7T2 7X7 7XB 88E 8C1 8FE 8FG 8FI 8FJ 8FK ABJCF ABUWG AEUYN AFKRA AN0 ATCPS AZQEC BENPR BGLVJ BHPHI C1K CCPQU COVID DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. L6V M0S M1P M7S PATMY PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS PTHSS PYCSY 7X8 5PM DOA |
DOI | 10.1186/s12889-023-16077-w |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health and Safety Science Abstracts (Full archive) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Public Health Database ProQuest SciTech Collection ProQuest Technology Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) Materials Science & Engineering Collection ProQuest Central (Alumni) ProQuest One Sustainability ProQuest Central UK/Ireland British Nursing Database Agricultural & Environmental Science Collection ProQuest Central Essentials ProQuest Central Technology Collection Natural Science Collection Environmental Sciences and Pollution Management ProQuest One Coronavirus Research Database ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) ProQuest Engineering Collection ProQuest Health & Medical Collection Medical Database Engineering Database Environmental Science Database ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China Engineering Collection Environmental Science Collection MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest Central Student Technology Collection ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China Environmental Sciences and Pollution Management ProQuest Central ProQuest One Applied & Life Sciences ProQuest One Sustainability ProQuest Health & Medical Research Collection ProQuest Engineering Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Agricultural & Environmental Science Collection Health & Safety Science Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) Engineering Collection Engineering Database ProQuest Public Health ProQuest One Academic Eastern Edition British Nursing Index with Full Text Coronavirus Research Database ProQuest Hospital Collection ProQuest Technology Collection Health Research Premium Collection (Alumni) ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) Environmental Science Collection ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition Materials Science & Engineering Collection Environmental Science Database ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | Publicly Available Content Database MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: 8FG name: ProQuest Technology Collection url: https://search.proquest.com/technologycollection1 sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Public Health Education |
EISSN | 1471-2458 |
EndPage | 11 |
ExternalDocumentID | oai_doaj_org_article_f3cfc5ae0d84460a8e5ac9fb22987112 PMC10265558 A764014937 37316843 10_1186_s12889_023_16077_w |
Genre | Clinical Trial Protocol Journal Article Research Support, N.I.H., Extramural |
GeographicLocations | Oklahoma United States United States--US |
GeographicLocations_xml | – name: Oklahoma – name: United States – name: United States--US |
GrantInformation_xml | – fundername: NIGMS NIH HHS grantid: U54 GM104938 – fundername: NCI NIH HHS grantid: P30 CA225520 – fundername: ; grantid: U54GM104938; U54GM104938; U54GM104938; U54GM104938; U54GM104938; U54GM104938; U54GM104938; U54GM104938; U54GM104938; U54GM104938; U54GM104938; U54GM104938; U54GM104938; U54GM104938 |
GroupedDBID | --- 0R~ 23N 2WC 2XV 44B 53G 5VS 6J9 6PF 7X7 7XC 88E 8C1 8FE 8FG 8FH 8FI 8FJ A8Z AAFWJ AAJSJ AASML AAWTL AAYXX ABDBF ABJCF ABUWG ACGFO ACGFS ACIHN ACIWK ACPRK ACUHS ADBBV ADUKV AEAQA AENEX AEUYN AFKRA AFPKN AFRAH AHBYD AHMBA AHYZX ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AN0 AOIJS ATCPS BAPOH BAWUL BCNDV BENPR BFQNJ BGLVJ BHPHI BMC BNQBC BPHCQ BVXVI C6C CCPQU CITATION CS3 DIK DU5 E3Z EAD EAP EAS EBD EBLON EBS EMB EMK EMOBN ESX F5P FYUFA GROUPED_DOAJ GX1 HCIFZ HMCUK HYE IAO IHR INH INR ITC KQ8 L6V M1P M48 M7S M~E O5R O5S OK1 OVT P2P PATMY PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO PTHSS PYCSY RBZ RNS ROL RPM RSV SMD SOJ SV3 TR2 TUS U2A UKHRP W2D WOQ WOW XSB CGR CUY CVF ECM EIF NPM PMFND 3V. 7T2 7XB 8FK AZQEC C1K COVID DWQXO GNUQQ K9. PJZUB PKEHL PPXIY PQEST PQGLB PQUKI PRINS 7X8 5PM PUEGO |
ID | FETCH-LOGICAL-c564t-4f1c735179f9492fba37e59761b485fbf94bb6eb643fd52d9e86ad48cbd2dc3c3 |
IEDL.DBID | M48 |
ISSN | 1471-2458 |
IngestDate | Wed Aug 27 01:10:23 EDT 2025 Thu Aug 21 18:37:49 EDT 2025 Thu Jul 10 20:00:16 EDT 2025 Fri Jul 25 10:22:17 EDT 2025 Tue Jun 17 22:19:49 EDT 2025 Tue Jun 10 21:21:24 EDT 2025 Thu Apr 03 06:54:28 EDT 2025 Thu Apr 24 23:10:05 EDT 2025 Tue Jul 01 00:56:54 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | COVID-19 Community-engaged intervention Vaccine hesitancy Underserved communities Rural health disparities Multiphase optimization strategy |
Language | English |
License | 2023. The Author(s). Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c564t-4f1c735179f9492fba37e59761b485fbf94bb6eb643fd52d9e86ad48cbd2dc3c3 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 content type line 14 ObjectType-Feature-3 ObjectType-Evidence Based Healthcare-1 ObjectType-Undefined-1 content type line 23 |
OpenAccessLink | https://doaj.org/article/f3cfc5ae0d84460a8e5ac9fb22987112 |
PMID | 37316843 |
PQID | 2827038878 |
PQPubID | 44782 |
PageCount | 11 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_f3cfc5ae0d84460a8e5ac9fb22987112 pubmedcentral_primary_oai_pubmedcentral_nih_gov_10265558 proquest_miscellaneous_2826217592 proquest_journals_2827038878 gale_infotracmisc_A764014937 gale_infotracacademiconefile_A764014937 pubmed_primary_37316843 crossref_citationtrail_10_1186_s12889_023_16077_w crossref_primary_10_1186_s12889_023_16077_w |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2023-06-14 |
PublicationDateYYYYMMDD | 2023-06-14 |
PublicationDate_xml | – month: 06 year: 2023 text: 2023-06-14 day: 14 |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: London |
PublicationTitle | BMC public health |
PublicationTitleAlternate | BMC Public Health |
PublicationYear | 2023 |
Publisher | BioMed Central Ltd BioMed Central BMC |
Publisher_xml | – name: BioMed Central Ltd – name: BioMed Central – name: BMC |
References | 16077_CR21 16077_CR25 IA Doherty (16077_CR14) 2021; 16 16077_CR29 16077_CR27 16077_CR28 E Nguyen (16077_CR23) 2022; 6 M Gwadz (16077_CR12) 2022; 22 JW Mold (16077_CR33) 2014; 12 LM Collins (16077_CR26) 2004; 5 16077_CR4 16077_CR3 16077_CR6 16077_CR30 16077_CR5 RD Hubach (16077_CR20) 2022; 22 16077_CR31 JW Mold (16077_CR34) 2014; 9 16077_CR8 NM Davoodi (16077_CR7) 2020; 6 16077_CR9 16077_CR13 16077_CR19 16077_CR17 KA Matthews (16077_CR10) 2021; 37 KH Nguyen (16077_CR11) 2021; 70 T Morrison (16077_CR22) 2022; 22 MJ Cima (16077_CR18) 2022; 40 ZJ Nagykaldi (16077_CR35) 2017; 30 R Robinson (16077_CR15) 2022; 9 LM Collins (16077_CR24) 2016; 20 JW Mold (16077_CR32) 2008; 21 NJ Patterson (16077_CR16) 2022; 22 16077_CR2 16077_CR1 |
References_xml | – ident: 16077_CR9 – ident: 16077_CR28 – ident: 16077_CR30 – volume: 5 start-page: 185 issue: 3 year: 2004 ident: 16077_CR26 publication-title: Prev Sci doi: 10.1023/B:PREV.0000037641.26017.00 – ident: 16077_CR19 doi: 10.1016/j.vaccine.2022.12.050 – ident: 16077_CR13 doi: 10.1007/s40615-022-01471-8 – ident: 16077_CR4 doi: 10.1080/13548506.2020.1750663 – ident: 16077_CR6 doi: 10.1111/jrh.12481 – volume: 37 start-page: 272 issue: 2 year: 2021 ident: 16077_CR10 publication-title: J Rural Health doi: 10.1111/jrh.12555 – volume: 22 start-page: 503 issue: 1 year: 2022 ident: 16077_CR16 publication-title: BMC Public Health doi: 10.1186/s12889-022-12900-y – volume: 9 start-page: 169 year: 2014 ident: 16077_CR34 publication-title: Implement Sci doi: 10.1186/s13012-014-0169-x – volume: 22 start-page: 7128 issue: 2 year: 2022 ident: 16077_CR20 publication-title: Rural Remote Health – volume: 12 start-page: 233 issue: 3 year: 2014 ident: 16077_CR33 publication-title: Ann Fam Med doi: 10.1370/afm.1624 – ident: 16077_CR25 – ident: 16077_CR2 – volume: 6 start-page: 233372142093616 year: 2020 ident: 16077_CR7 publication-title: Gerontol Geriatr Med doi: 10.1177/2333721420936168 – ident: 16077_CR17 doi: 10.1016/j.japh.2022.01.013 – volume: 16 start-page: e0248542 issue: 11 year: 2021 ident: 16077_CR14 publication-title: PLoS ONE doi: 10.1371/journal.pone.0248542 – ident: 16077_CR8 – ident: 16077_CR29 – volume: 22 start-page: 1235 issue: 1 year: 2022 ident: 16077_CR12 publication-title: BMC Public Health doi: 10.1186/s12889-022-13576-0 – ident: 16077_CR27 – ident: 16077_CR31 – volume: 40 start-page: 5523 issue: 37 year: 2022 ident: 16077_CR18 publication-title: Vaccine doi: 10.1016/j.vaccine.2022.07.045 – ident: 16077_CR21 doi: 10.1016/j.ypmed.2022.107415 – volume: 21 start-page: 334 issue: 4 year: 2008 ident: 16077_CR32 publication-title: J Am Board Fam Med doi: 10.3122/jabfm.2008.04.080006 – volume: 30 start-page: 583 issue: 5 year: 2017 ident: 16077_CR35 publication-title: J Am Board Fam Med doi: 10.3122/jabfm.2017.05.170035 – ident: 16077_CR3 – volume: 22 start-page: 7140 issue: 3 year: 2022 ident: 16077_CR22 publication-title: Rural Remote Health – ident: 16077_CR1 – volume: 9 start-page: 416 issue: 1 year: 2022 ident: 16077_CR15 publication-title: Humanit Soc Sci Commun doi: 10.1057/s41599-022-01439-3 – volume: 20 start-page: 197 issue: Suppl 10 1 year: 2016 ident: 16077_CR24 publication-title: AIDS Behav doi: 10.1007/s10461-015-1145-4 – volume: 6 start-page: e39109 issue: 12 year: 2022 ident: 16077_CR23 publication-title: JMIR Form Res doi: 10.2196/39109 – ident: 16077_CR5 – volume: 70 start-page: 217 issue: 6 year: 2021 ident: 16077_CR11 publication-title: MMWR Morb Mortal Wkly Rep doi: 10.15585/mmwr.mm7006e3 |
SSID | ssj0017852 |
Score | 2.3936324 |
Snippet | Oklahoma's cumulative COVID-19 incidence is higher in rural than urban counties and higher than the overall US incidence. Furthermore, fewer Oklahomans have... Background Oklahoma's cumulative COVID-19 incidence is higher in rural than urban counties and higher than the overall US incidence. Furthermore, fewer... BackgroundOklahoma’s cumulative COVID-19 incidence is higher in rural than urban counties and higher than the overall US incidence. Furthermore, fewer... Abstract Background Oklahoma’s cumulative COVID-19 incidence is higher in rural than urban counties and higher than the overall US incidence. Furthermore,... |
SourceID | doaj pubmedcentral proquest gale pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 1146 |
SubjectTerms | Clinical trials Collaboration Communication Community Community involvement Community-engaged intervention COVID-19 COVID-19 - epidemiology COVID-19 - prevention & control COVID-19 diagnostic tests COVID-19 Testing COVID-19 Vaccines Demographic aspects Design optimization Education Educational materials Evaluation Factorial design Focus groups Health care disparities Humans Immunization Intervention Leadership Multiphase Multiphase optimization strategy Oklahoma - epidemiology Optimization Pandemics Public health Randomized Controlled Trials as Topic Rural areas Rural health Rural health care Rural health disparities Social aspects Study Protocol Underserved communities Underserved populations Vaccine hesitancy Vaccines |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3di9QwEA9yT4KI31ZPGUFQkXLbNk1T39bV4xR0BW_l3kKaD2-5vfZwux76P_o_OZO2yxZBX3xbmumSdCbz0f7yG8ae5tLkEyNFnIRXN7YkEIB3MaXuqcUAqH1AW3wURwv-_iQ_2Wn1RZiwjh64e3AHPjPe5NpNrMTKZaKly7UpfZWmWC0nob9wijFvKKb67weFzNPhiIwUB2v0wgQNSrOYCNWK-HIUhgJb_58-eScojQGTOxHo8Aa73qeOMO2mfJNdcfUtdq177wbdcaLb7Ndsejw7ihef4Ls29NF8_QqIi6FBhQMmqKABo5Ntzpc_nYUeqL7Cn6F9BxAM_itgUggd0vAUgxw06FbO-_OasO7obH_A8w_zz8cvwA_oLmgb6LnDHbgBNwLLHVDlmmSWNSWq-Lez-Zd3b-KkHGYKm4tWnzkUgPnZShNy6Q5bHL6l9fQtG2KTC97G3CemyIj2y5e8TH2ls8JhzSKSisvcV3i1qoSrMA_yFo2hdFJoy6WpbGpNZrK7bK9uanefgfdcyERbYxLLCy1KVxXa-DTzzkh0RRFLBg0q0_OZU1uNlQp1jRSq07pCraugdXUZsZfbey46No-_Sr8mw9hKEhN3uID2qXr7VP-yz4g9I7NS5C9wekb3xx5wkcS8paaF4FSmZkXE9keSuM_NeHgwTNX7mbXCgrkgPp9CRuzJdpjuJOxc7ZpNkBFYeOYlzuVeZ8fbJWWhcRnPIiZHFj5a83ikXp4GFnLc3ILI4h78j6f0kF1NaXdSUyi-z_babxv3CLO9tnocNvZv11ZV3A priority: 102 providerName: Directory of Open Access Journals – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1ba9RAFB60vggiWi-NVhlBUJHQzW0y8UXW1VIFXcGu7NswmUu7dJusTdai_9H_5DmTybpB6FvInIQZcq6Tb75DyPOMq2ykOAsjt3WjCwQBWBNi6h5rCIDSOrTFF3Y0Sz_Ns7nfcGs8rLL3ic5R61rhHvkBlAY5Mpfk_O3qR4hdo_Dvqm-hcZ3cQOoyhHTl803BhY3n4_6gDGcHDfhiBAjFSYi0anl4OQhGjrP_f8-8FZqGsMmtOHR4h9z2CSQdd1_8Lrlmql3svexxGrvkVrcTR7sDRvfIn8n4eHIUzr7Sn1Lhb_TmDUV2hhpUgELKSiWFeKXr88Vvo6mHri_h0jX0oAiMP6GQJtIOe3gKYY_W4GjO_QlO2nQEt7_oy8_Tb8evqO3xXrStqWcTN9T0M6SLLZhlgzKLClNXeO1k-v3j-zAq-pnS9aqVZwYE6PRsKRHLdJ_MDj_genwTh1BlLG3D1EYqT5AIzBZpEdtSJrmBKoZFZcozW8LdsmSmhMzIalCPwnAmdcpVqWOtEpU8IDtVXZk9Qq1NGY-kVirSaS5ZYcpcKhsn1igOzikgUf81hfIM59hoYylcpcOZ6DRAgAYIpwHiMiCvN8-sOn6PK6XfoZJsJJGb292oL06EN3VhE2VVJs1Ic6i1R5KbTKrClnFcQHUaxQF5gSom0IPA9JT0ByFgkcjFJcY5S7FwTfKA7A8kwfLVcLhXUuE9TyP-2UlAnm2G8UlE01WmXjsZBqVoVsBcHnY6vVlS4lqZpUlA-EDbB2sejlSLU8dLDubOkD7u0dXzekxuxmiD2AAq3Sc77cXaPIHMri2fOvP9C5A7ULU priority: 102 providerName: ProQuest |
Title | CATCH-UP vaccines: protocol for a randomized controlled trial using the multiphase optimization strategy (MOST) framework to evaluate education interventions to increase COVID-19 vaccine uptake in Oklahoma |
URI | https://www.ncbi.nlm.nih.gov/pubmed/37316843 https://www.proquest.com/docview/2827038878 https://www.proquest.com/docview/2826217592 https://pubmed.ncbi.nlm.nih.gov/PMC10265558 https://doaj.org/article/f3cfc5ae0d84460a8e5ac9fb22987112 |
Volume | 23 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1tb9MwELb2IqFJCPFOYFRGQgKEAs2b7SAh1JaVgbR1Giuq-BI5jr1V65LRF8b4j_wn7pykNGLwxariS2Snz_nunPNzhDyNhIraSjDXs1s3WYxJAEa76Lr7GRhAaWy2xT7bHYafRtFojdTljqoXOLsytMN6UsPp5NWPb5fvQOHfWoUX7PUM1lhM_PEDF-nSuHuxTjbBMnFU1L3wz1cFLiK_Pjhz5X1b5FpgSzmFQcNOWTr_vxftFavVzKhcMVH9m-RG5VvSTgmGW2RN57fJ9XJjjpbnje6QX73OUW_XHR7Q71LhV_XZG4pkDQUggoIHSyUF85UVZ-OfOqNVJvsEftr6HhTz5I8peI20TEU8AStIC1h3zqoDnXRW8t1e0ud7g89HL6ip07_ovKAVubimuk4soeOVrMsZyoxz9GThsb3Bl4_vXS-uR0oX53N5qkGADk4nElOb7pJhfwfnU9V0cFXEwrkbGk_xAHnBTBzGvkllwDUENcxLQxGZFK6mKdMpOEomA7TEWjCZhUKlmZ-pQAX3yEZe5PoBocaETHgyU8rLQi5ZrFMulfEDo5WAtcohXv0PJqoiPMe6G5PEBj6CJSUAEgBAYgGQXDjk5fKe85Lu47_SXQTGUhKpuu2FYnqcVJqfmEAZFUndzgSE3m0pdCRVbFLfjyFY9XyHPENYJQhxGJ6S1bkImCRScyUdzkKMYwPukO2GJCwEqtldAzOp9SiBiJoj4Q8XDnmy7MY7Mbku18XCyjCITKMYxnK_xPFySrU6OEQ0EN6Yc7MnH59YmnLQfoZscg__-dBHZMtH7cNSUOE22ZhPF_ox-HjztEXW-YhDK3oetv0PLbLZ3dk_OGzZXZOWVWxoD7tffwOjeFZv |
linkProvider | Scholars Portal |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFLbGeAAJIRi3wAAjgQBN0Zqb4yAhVDqmlV2KRIv6ZhzH3qp1SVlbqvGj-Cf8J85xktIIaW97q5KT6Lg-Phfn83cIeRlxFbUUZ65nt26yBEEARruYuvsZBEBpLNriiO0Nws_DaLhGftdnYRBWWftE66izQuEe-TaUBjEyl8T8w-SHi12j8Otq3UKjNIt9fbGAkm36vrsD8_vK93c_9Tt7btVVwFURC2duaDwVB8hMZZIw8U0qg1hDWs28NOSRSeFqmjKdQqg2GeibaM5kFnKVZn6mAhXAe6-R6xB4W7ii4uGywMNG9359MIez7Sn4fgQk-YGLNG6xu2gEP9sj4P9IsBIKmzDNlbi3e4fcrhJW2i4t7C5Z0_kG9nqucCEb5Fa580fLA033yJ9OG_-OwRf6Uyr8bD99R5ENogCTo5AiU0khPmbF2eiXzmgFlR_DT9tAhCIQ_5hCWkpLrOMJhFlagGM7q06M0mlJqHtB3xz2vvbfUlPjy-isoBV7uaa61pCOVmCdU5QZ5Zgqw2s7vW_dHddLak3pfDKTpxoEaO90LBE7dZ8MrmR6H5D1vMj1I0KNCRn3ZKaUl4WxZIlOY6mMHxitODhDh3j1bApVMapjY4-xsJUVZ6K0AAEWIKwFiIVDtpbPTEo-kUulP6KRLCWRC9xeKM6PReVahAmUUZHUrYxDbd-SXEdSJSb1_QSqYc93yGs0MYEeC9RTsjp4AYNE7i_RjlmIhXIQO2SzIQmeRjVv10YqKk83Ff_WpUNeLG_jk4jey3UxtzIMSt8oAV0elja9HFJgW6eFgUN4w9obY27eyUcnlgcd3AtDurrHl-v1nNzY6x8eiIPu0f4TctPH9YjNp8JNsj47n-unkFXO0md2KVPy_ap9x19vsI68 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=CATCH-UP+vaccines%3A+protocol+for+a+randomized+controlled+trial+using+the+multiphase+optimization+strategy+%28MOST%29+framework+to+evaluate+education+interventions+to+increase+COVID-19+vaccine+uptake+in+Oklahoma&rft.jtitle=BMC+public+health&rft.au=Janitz%2C+Amanda+E&rft.au=Neil%2C+Jordan+M&rft.au=Bray%2C+Laura+A&rft.au=Jervis%2C+Lori+L&rft.date=2023-06-14&rft.eissn=1471-2458&rft.volume=23&rft.issue=1&rft.spage=1146&rft_id=info:doi/10.1186%2Fs12889-023-16077-w&rft_id=info%3Apmid%2F37316843&rft.externalDocID=37316843 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2458&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2458&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2458&client=summon |